Oncology

A new phase 3 trial (INTERLACE) shows that adding induction chemotherapy to standard chemoradiotherapy improves both progression-free and overall survival in patients with locally advanced cervical cancer.

A new study reveals how the m6A epitranscriptomic modification and MYCN oncogene cooperate to maintain an undifferentiated state in neuroblastoma…

Researchers have developed a novel treatment for non-small cell lung cancer (NSCLC) that uses customised antisense oligonucleotides (ASOs) to selectively target drug-resistant EGFR mutations.

A recent trial found that three cycles of CEV chemotherapy are as effective as six in treating high-risk unilateral retinoblastoma after enucleation.

A recent study uncovers genetic vulnerabilities in glioblastoma stem cells, pinpointing subtype-specific dependencies that drive tumour growth.

A recent study reveals that family members of cancer patients are at greater risk for developing psychological illnesses and cardiovascular diseases. The research highlights the need for better healthcare support for families coping with cancer.

A new clinical trial has found that extended lymphadenectomy does not improve disease-free or overall survival rates compared to standard lymphadenectomy in patients with localized muscle-invasive bladder cancer.

A recent analysis of the National Cancer Database reveals that health insurance plays a crucial role in racial and ethnic disparities in late-stage cancer diagnoses.